Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
OS
0913693 B.C. LTD
No one on the platform currently holds REPCF.
No tracked institution reports a position in REPCF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2016-08-10 | 1-for-10reverse |
No one on the platform has traded REPCF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| REPCFRepliCel Life Sciences Inc. | $0.00 | +0.00% | $7357 | — |
| CVMCEL-SCI Corporation | $1.52 | +2.01% | $10M | — |
| EXELExelixis, Inc. | $51.06 | +0.90% | $12.8B | — |
| INCYIncyte Corporation | $120.17 | -0.29% | $24.4B | — |
| JAGXJaguar Health, Inc. | $0.77 | -1.70% | $51299 | — |
| PKTXProtoKinetix, Incorporated | $0.00 | +0.00% | $195790 | — |
| REPLReplimune Group, Inc. | $15.07 | -0.76% | $1.3B | — |
Source: Financial Modeling Prep · peers by sector/industry